Evidence map›Paper›PMID 40918541›Full record

ArticleCHEST pulmonary2025

Delays in Referral to Multidisciplinary Care for Black Individuals With Sarcoidosis.

Kristen R Mathias, Ofure Akhiwu, Ali M Mustafa, Kevin J Psoter, Edward S Chen, Nisha A Gilotra, Nancy W Lin, John Odackal, Catherine A Bonham, Michelle Sharp

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CHEST pulmonary, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Kristen R MathiasDivision of Rheumatology (K. R. M.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary & Critical Care (O. A.), Yale School of Medicine, New Haven, CT; the Divisions of Pulmonary & Critical Care Medicine (A. M. M., E. S. C., N. W. L., and M. S.), and Cardiology (N. A. G.), and Department of General Pediatrics (K. J. P.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary, Critical Care & Sleep Medicine (J. O.), The Ohio State University, Columbus, OH; and the Division of Pulmonary & Critical Care (C. A. B.), University of Virginia, Charlottesville, VA.
Ofure AkhiwuDivision of Rheumatology (K. R. M.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary & Critical Care (O. A.), Yale School of Medicine, New Haven, CT; the Divisions of Pulmonary & Critical Care Medicine (A. M. M., E. S. C., N. W. L., and M. S.), and Cardiology (N. A. G.), and Department of General Pediatrics (K. J. P.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary, Critical Care & Sleep Medicine (J. O.), The Ohio State University, Columbus, OH; and the Division of Pulmonary & Critical Care (C. A. B.), University of Virginia, Charlottesville, VA.
Ali M MustafaDivision of Rheumatology (K. R. M.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary & Critical Care (O. A.), Yale School of Medicine, New Haven, CT; the Divisions of Pulmonary & Critical Care Medicine (A. M. M., E. S. C., N. W. L., and M. S.), and Cardiology (N. A. G.), and Department of General Pediatrics (K. J. P.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary, Critical Care & Sleep Medicine (J. O.), The Ohio State University, Columbus, OH; and the Division of Pulmonary & Critical Care (C. A. B.), University of Virginia, Charlottesville, VA.
Kevin J PsoterDivision of Rheumatology (K. R. M.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary & Critical Care (O. A.), Yale School of Medicine, New Haven, CT; the Divisions of Pulmonary & Critical Care Medicine (A. M. M., E. S. C., N. W. L., and M. S.), and Cardiology (N. A. G.), and Department of General Pediatrics (K. J. P.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary, Critical Care & Sleep Medicine (J. O.), The Ohio State University, Columbus, OH; and the Division of Pulmonary & Critical Care (C. A. B.), University of Virginia, Charlottesville, VA.
Edward S ChenDivision of Rheumatology (K. R. M.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary & Critical Care (O. A.), Yale School of Medicine, New Haven, CT; the Divisions of Pulmonary & Critical Care Medicine (A. M. M., E. S. C., N. W. L., and M. S.), and Cardiology (N. A. G.), and Department of General Pediatrics (K. J. P.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary, Critical Care & Sleep Medicine (J. O.), The Ohio State University, Columbus, OH; and the Division of Pulmonary & Critical Care (C. A. B.), University of Virginia, Charlottesville, VA.
Nisha A GilotraDivision of Rheumatology (K. R. M.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary & Critical Care (O. A.), Yale School of Medicine, New Haven, CT; the Divisions of Pulmonary & Critical Care Medicine (A. M. M., E. S. C., N. W. L., and M. S.), and Cardiology (N. A. G.), and Department of General Pediatrics (K. J. P.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary, Critical Care & Sleep Medicine (J. O.), The Ohio State University, Columbus, OH; and the Division of Pulmonary & Critical Care (C. A. B.), University of Virginia, Charlottesville, VA.
Nancy W LinDivision of Rheumatology (K. R. M.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary & Critical Care (O. A.), Yale School of Medicine, New Haven, CT; the Divisions of Pulmonary & Critical Care Medicine (A. M. M., E. S. C., N. W. L., and M. S.), and Cardiology (N. A. G.), and Department of General Pediatrics (K. J. P.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary, Critical Care & Sleep Medicine (J. O.), The Ohio State University, Columbus, OH; and the Division of Pulmonary & Critical Care (C. A. B.), University of Virginia, Charlottesville, VA.
John OdackalDivision of Rheumatology (K. R. M.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary & Critical Care (O. A.), Yale School of Medicine, New Haven, CT; the Divisions of Pulmonary & Critical Care Medicine (A. M. M., E. S. C., N. W. L., and M. S.), and Cardiology (N. A. G.), and Department of General Pediatrics (K. J. P.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary, Critical Care & Sleep Medicine (J. O.), The Ohio State University, Columbus, OH; and the Division of Pulmonary & Critical Care (C. A. B.), University of Virginia, Charlottesville, VA.
Catherine A BonhamDivision of Rheumatology (K. R. M.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary & Critical Care (O. A.), Yale School of Medicine, New Haven, CT; the Divisions of Pulmonary & Critical Care Medicine (A. M. M., E. S. C., N. W. L., and M. S.), and Cardiology (N. A. G.), and Department of General Pediatrics (K. J. P.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary, Critical Care & Sleep Medicine (J. O.), The Ohio State University, Columbus, OH; and the Division of Pulmonary & Critical Care (C. A. B.), University of Virginia, Charlottesville, VA.
Michelle SharpDivision of Rheumatology (K. R. M.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary & Critical Care (O. A.), Yale School of Medicine, New Haven, CT; the Divisions of Pulmonary & Critical Care Medicine (A. M. M., E. S. C., N. W. L., and M. S.), and Cardiology (N. A. G.), and Department of General Pediatrics (K. J. P.), Johns Hopkins University, Baltimore, MD; the Division of Pulmonary, Critical Care & Sleep Medicine (J. O.), The Ohio State University, Columbus, OH; and the Division of Pulmonary & Critical Care (C. A. B.), University of Virginia, Charlottesville, VA.

Funding

MULTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASEST32HL007534 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Nadia N Hansel, Larissa A. Shimoda · 1985 to 2026
$28.3M
Multidisciplinary Rheumatology Training ProgramT32AR048522 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CLIFTON O BINGHAM, LIVIA A CASCIOLA-ROSEN · 2003 to 2026
$6.4M
Medication Adherence and Clinical Outcomes in SarcoidosisK23HL148527 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SHARP, MICHELLE · 2021 to 2025
$886k
MicroRNA as Diagnostic and Prognostic Biomarkers in SarcoidosisK23HL163313 · NHLBI · NATIONAL JEWISH HEALTH · PI Nancy Weijiun Lin · 2023 to 2026
$872k
NHLBI NIH HHS K23 HL148527NHLBI NIH HHS K23 HL163313NHLBI NIH HHS T32 HL007534NIAMS NIH HHS T32 AR048522
6 · The paper itself

Abstract

backgroundSarcoidosis is a complex granulomatous disease that benefits from multidisciplinary subspecialty expertise. Inequitable access to care contributes to racial disparities in many diseases; however, to our knowledge, no studies have examined racial differences in referral times to Sarcoidosis Centers of Excellence. RESEARCH QUESTION: Is there an association between race and time from sarcoidosis diagnosis to referral to an independently certified, peer-reviewed World Association of Sarcoidosis and Other Granulomatous Disorders Center of Excellence? Does a referral result in a change in sarcoidosis management? STUDY DESIGN AND

methodsWe retrospectively reviewed all 2021 referrals to the Johns Hopkins Sarcoidosis Center of Excellence. Multivariable Cox regression evaluated the association between race and time to referral, adjusting for covariates of sex, ethnicity, referral type, referral provider, insurance provider, employment status, organ involvement, and sarcoidosis medications. Changes in sarcoidosis management including treatment changes, additional organ evaluation, and/or additional subspecialty expertise were ascertained 1 year after establishing care.

resultsAt total of 207 individuals were analyzed (40% Black, 55% White, and 5% Asian and other race). Black individuals experienced longer referral delay than White individuals, with a median of 9 vs 5 years, respectively (

interpretationBlack patients experienced significant delays in referral to a multidisciplinary subspecialty Sarcoidosis Center of Excellence compared with other racial groups. Recognition of referral delay may offer insight and opportunity to address disparities in clinical outcomes observed in Black individuals with sarcoidosis. Future multicenter studies must quantify the impact of care received through World Association of Sarcoidosis and Other Granulomatous Disorders Sarcoidosis Centers of Excellence, define patient phenotypes in need of urgent referral, and develop targeted patient and provider outreach.

Indexed as

access to carehealth equitymultidisciplinary careracial disparitiessarcoidosis

Identifiers

PMID40918541
PMCPMC12413202

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.